UC San Diego Institute of Engineering in Medicine (IEM)

What UC San Diego Institute of Engineering in Medicine (IEM) does

The Institute of Engineering in Medicine (IEM) is an academic research institute established in 2008 within UC San Diego, operated under the university's Jacobs School of Engineering and governed by the Regents of the University of California. It coordinates translational research across UC San Diego's Schools of Medicine, Skaggs School of Pharmacy & Pharmaceutical Sciences, and Jacobs School of Engineering, drawing on more than 130 faculty and maintaining a core staff of 17. IEM's stated mission is to bridge engineering innovation and clinical medicine, with research spanning biofabrication, nanomedicine, biomedical imaging, wearable sensors, and regenerative medicine.

IEM's technology portfolio includes 3D bioprinting via Dynamic Optical Projection Stereolithography (DOPsL), an injectable hydrogel for cardiac repair (licensed to Ventrix, Inc.), zinc-based stomach-acid-fueled micromotors for in vivo drug delivery, platelet-membrane-cloaked nanoparticles for targeted vascular delivery, near-infrared light-triggered drug release systems, and a non-wrinkling biomaterial with a negative Poisson's ratio for tissue engineering. It runs multiple centers (e.g., San Diego Skeletal Muscle Research Center, Center for Perinatal Health) and structured programs (GEM, GEMSTONES, OPALS, GEMINI, Siebel Scholars, J. Yang Scholarship, MAS in Medical Device Engineering). Clinical translation is enabled through partnerships with UC San Diego Health, Rady Children's Hospital-San Diego, Sharp Mary Birch Hospital for Women and Newborns, and the Shiley Center for Orthopaedic Research and Education at Scripps Clinic.

IEM does not sell products or services. Its operating model is a hybrid of (a) competitive federal grant capture — NIH, NSF, CIRM (over $150M cumulative to UCSD researchers since 2006), and ARPA-H — supporting PI-led research; (b) philanthropic donations and endowments (e.g., $3M endowed directorships, $10M for 10 endowed chairs) channeled through UC San Diego; and (c) technology licensing and commercialization via startups such as Ventrix, Inc. Distribution of "output" occurs through research publications, talent pipeline (6,000+ bioengineering alumni), licensing to industry, and clinical partnerships within the regional San Diego biomedical cluster that includes Salk, Sanford-Burnham, SDSU, and Scripps Research.

Name

UC San Diego Institute of Engineering in Medicine (IEM)

Legal name

Institute of Engineering in Medicine (IEM), UC San Diego

Website

https://iem.ucsd.edu

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

The UC San Diego Institute of Engineering in Medicine (IEM) is an academic research institute that coordinates 130+ faculty across engineering, medicine, and pharmacy to translate biomedical technologies — including 3D bioprinting, injectable hydrogels, nanomedicine, and wearable sensors — into clinical applications, funded by federal grants, philanthropy, and licensing.

Ownership category

akta.pro rank

Product category

Biomedical Research Institute

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Engineering Services (541330)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700), Services-Engineering Services (8711)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Technical Universities with Specialized Engineering Domains (EDAHAEAI), Global Health Institutes & Programs (EDAHAGAM)

Keywords

• Biomedical research
• Translational medicine
• Tissue engineering
• Regenerative medicine
• Nanomedicine research

Headquarters

HQ city

La Jolla

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Government Research Grants: Primary funding from federal agencies including NIH, NSF, CIRM (California Institute for Regenerative Medicine), and ARPA-H for research initiatives and projects
2. Philanthropic Donations and Endowments: Donations supporting Engineering in Medicine Initiative, centers, labs, and initiatives including endowed directorships ($3M) and endowed chairs ($10M)
3. Technology Licensing and Commercialization: Licensing of developed technologies to industry partners and startups such as Ventrix, Inc. for clinical development

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

The Institute of Engineering in Medicine (IEM) at UC San Diego is an academic research institute that coordinates interdisciplinary collaboration between UC San Diego's engineering and medical faculties to translate engineering innovations into clinical applications. It offers educational and fellowship programs (GEM, GEMSTONES, GEMINI, Siebel Scholars, J. Yang Scholarship, OPALS), operates specialized research laboratories (Berns Lab, Chien Lab, McCulloch Lab), and conducts research in biofabrication, nanomedicine, biomedical imaging, wearable sensors, and regenerative medicine.

Product overview

The Institute of Engineering in Medicine (IEM) at UC San Diego is an academic institute, not a product company. It operates as a collaborative entity coordinating engineering and medical research across UC San Diego's Schools of Medicine, Skaggs School of Pharmacy, and Jacobs School of Engineering. IEM's offerings include educational programs (GEM, OPALS, GEMSTONES, GEMINI, Siebel Scholars, J. Yang Scholarship), research laboratories (Berns Lab, Chien Lab, McCulloch Lab), and communication platforms (IEM Newsletter). The institute focuses on translating engineering innovations into clinical applications rather than commercial products.

Differentiator

Problem solved

Functional benefit

Brands

• GEM (Galvanizing Engineering in Medicine): A program where clinically active UCSD faculty propose clinical challenges in need of engineering solutions
• GEMSTONES
• OPALS
• GEMINI
• Siebel Scholars
• J. Yang Scholarship

Products and services

• GEM (Galvanizing Engineering in Medicine)

Quantifiable outcome

• UC San Diego Bioengineering ranked #1 nationally by National Research Council
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eleven partnerships are on record, tiered core and notable.

• UC San Diego Altman Clinical and Translational Research Institute (ACTRI)coreStrategic or Co-development PartnerJoint sponsor of the Galvanizing Engineering in Medicine (GEM) program that brings clinicians and engineers together to develop innovative medical technology solutions
• UC San Diego Jacobs School of EngineeringcoreStrategic or Co-development PartnerPrimary academic partner providing engineering faculty and resources for IEM research initiatives
• San Diego Skeletal Muscle Research Center PartnerscoreStrategic or Co-development PartnerCollaboration spanning 5 institutions: Salk Institute, Sanford-Burnham Medical Research Institute, San Diego State University, The Scripps Research Institute, and UC San Diego with 21 scientists across 9 departments
• Bose CorporationnotableTechnology or IntegrationBose has been an invaluable member of the IEM Industrial Advisory Board, helping translate innovative research to clinical application and commercialization. Joint technology forum held in 2014.
• Bioengineering Institute of CAnotableStrategic or Co-development PartnerCross-institutional collaboration in bioengineering research
• University System of Taiwan (UST)notableStrategic or Co-development PartnerInternational research partnership with National Yang-Ming University and National Chiao-Tung University through I-RiCE (International Research-intensive Center of Excellence) on Advanced Bioengineering since 2010
• Ventrix, Inc.coreOEM/ Whitelabel/ Licensing PartnerSan Diego-based startup licensing Karen Christman's injectable hydrogel technology for planning first human clinical trials; Dr. Christman is co-founder
• Whitaker Center for Biomedical EngineeringcoreStrategic or Co-development PartnerCollaboration in biomedical engineering research and education
• Sanford Stem Cell Clinical Center at UC San Diego HealthnotableStrategic or Co-development PartnerUC San Diego is one of three sites in CIRM Alpha Clinics network for cell therapy development
• UC San Diego HealthcoreStrategic or Co-development PartnerClinical partner for translation of engineering innovations to patient care
• Industry Advisory BoardcoreStrategic or Co-development PartnerAdvisory committee of industry leaders providing guidance, advice, and industry connections for IEM initiatives

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Wyss Institute for Biologically Inspired Engineering: Harvard University-based interdisciplinary research institute focused on biologically inspired engineering and translational medical technologies. Direct peer: similar university-affiliated model combining engineering, medicine, and biology, with comparable industry partnership programs, IP licensing, and biomedical device/translational research focus.
• Gladstone Institutes: UCSF-affiliated independent research organization focused on biomedical research with translational and industry partnership programs. Comparable to IEM as a San Francisco Bay Area parallel in university-affiliated biomedical research with strong technology transfer orientation.
• Koch Institute for Integrative Cancer Research at MIT: MIT-based cancer research institute integrating engineering and science with oncology, similar in structure to IEM in bridging engineering and clinical medicine. Direct peer given comparable model: university-based, interdisciplinary faculty structure, strong industry/industry affiliate program, and translational pipeline.
• Georgia Tech Petit Institute for Bioengineering and Bioscience: University-based bioengineering and bioscience research institute at Georgia Tech. Direct peer in operating model: faculty-collaborative translational research, industry partnership programs, and bioengineering focus aligned with UCSD Bioengineering.
• Stanford BioX: Stanford University interdisciplinary biosciences institute bringing together biology, engineering, and medicine. Direct peer in operating model (university-based, faculty-collaborative, interdisciplinary research, industry affiliate program) and translational focus.
• Case Western Reserve University Center for Engineering in Medicine: University-based institute with the same exact naming convention and mission: integrating engineering and medicine. Direct peer in scope, structure, and translational research focus, and the most obvious name-institutional parallel to IEM.

Broad incumbents

• Johns Hopkins Biomedical Engineering: Top-tier biomedical engineering program housed within Johns Hopkins School of Medicine, integrating engineering and clinical medicine. Comparable as a top-5 BME department with strong industry partnership and translational infrastructure, but operating within a broader medical school rather than as a standalone institute.

Regional players

• Scripps Research Institute: San Diego-based biomedical research institute and explicit IEM partner institution. Regional peer in the same biomedical ecosystem, with overlapping faculty and clinical translation networks, though with a broader life sciences rather than engineering-medicine focus.
• Salk Institute for Biological Studies: San Diego-based biomedical research institute and IEM partner institution within the Skeletal Muscle Research Center collaboration. Regional peer with overlapping faculty and translational research mission.

Emerging players

• Simpson Querrey Institute for BioNanotechnology (Northwestern): Northwestern University-based institute focused on bionanotechnology and regenerative medicine, with translational orientation comparable to IEM's nanomedicine and regenerative medicine focus. Emerging peer with similar mission but more focused thematic scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ucsdiem

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UC San Diego Institute of Engineering in Medicine (IEM)